Legault Pierre's Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Jan 13, 2023
- Accession no.
- 0001562180-23-000413
- Filed
- Jan 13, 2023
- Trade date
- Jan 12-13, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.05M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Legault PierreCIK 0001391045 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2023 | Common Stock | MOption exerciseAcquired | +24,000 | $9.47 | +$227,280 | 56,000 | Direct | |
| Jan 12, 2023 | Common Stock | SSaleDisposed | −24,000 | $26.74 | −$641,760 | 32,000 | Direct | |
| Jan 13, 2023 | Common Stock | MOption exerciseAcquired | +10,000 | $13.58 | +$135,800 | 42,000 | Direct | |
| Jan 13, 2023 | Common Stock | SSaleDisposed | −10,000 | $27.00 | −$270,000 | 32,000 | Direct | |
| Jan 13, 2023 | Common Stock | MOption exerciseAcquired | +5,000 | $13.58 | +$67,900 | 37,000 | Direct | |
| Jan 13, 2023 | Common Stock | SSaleDisposed | −5,000 | $27.00 | −$135,000 | 32,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2023 | Common Stock | MOption exerciseDisposed | −24,000 | $0.00 | $0 | 0 | Direct | |
| Jan 13, 2023 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Jan 13, 2023 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.